Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Skin Neoplasms
×
pembrolizumab
×
Clear all
Filters
3
NCT06295809
2026-03-27
INTerpath-007
Merck Sharp & Dohme LLC
Phase 2/3
Completed
46 enrolled
NCT07436390
2026-03-02
MAK
Institute of Oncology Ljubljana
Phase NA
Completed
132 enrolled